# Varex Imaging Corporation (VREX) Stock Analysis: Exploring a Potential 100% Upside

- Link: https://www.directorstalkinterviews.com/varex-imaging-corporation-vrex-stock-analysis-exploring-a-potential-100-upside/4121200481
- Published: 2025-06-05T10:17:25+01:00
- Author: Madison Wilson

Investors looking for opportunities in the healthcare sector may find Varex Imaging
Corporation (NASDAQ: VREX) an intriguing prospect. Despite challenges reflected 
in its recent financial performance, the company’s stock currently offers a potential
upside of 100.97%, making it worth a closer examination.

**Company Overview**

Varex Imaging Corporation, headquartered in Salt Lake City, Utah, is a prominent
player in the medical devices industry. The company specializes in designing, manufacturing,
and selling X-ray imaging components through its Medical and Industrial segments.
Its medical products are integral to various diagnostic radiography applications,
while the industrial segment supports security and inspection functions worldwide.

**Current Market Position**

Varex holds a market capitalization of approximately $342.9 million, with shares
currently trading at $8.26. The stock has experienced significant volatility, with
a 52-week range between $6.88 and $16.68. This volatility presents potential entry
points for investors as the stock hovers near the lower end of its annual range.

**Valuation and Performance Metrics**

The company reports a forward P/E ratio of 11.09, suggesting that investors are 
pricing in expectations of future earnings growth. Despite a lack of clarity on 
trailing P/E and PEG ratios, the forward-looking metrics indicate potential value.

However, Varex’s recent performance metrics reveal challenges. With a return on 
equity of -7.17% and an EPS of -1.03, the company is currently operating at a loss.
On a positive note, revenue growth of 3.20% and a free cash flow of $53.39 million
indicate that Varex is generating cash, which could support future investments and
debt management.

**Analyst Ratings and Potential Upside**

Analysts remain optimistic, with four buy ratings and one hold rating, and no sell
recommendations. The consensus target price averages at $16.60, with a high estimate
of $23.00, implying a potential upside of over 100% from the current price. This
optimistic outlook reflects confidence in the company’s strategic direction and 
potential for market recovery.

**Technical Indicators**

From a technical perspective, Varex’s stock is underperforming in terms of its moving
averages, with the 50-day moving average at $8.49 and the 200-day moving average
at $12.08. The relative strength index (RSI) of 27.94 suggests that the stock is
oversold, potentially signaling a buying opportunity for contrarian investors.

**Investment Considerations**

While Varex Imaging faces operational challenges, its strong cash flow and diverse
product offerings in critical healthcare and industrial applications offer a foundation
for growth. The company’s global reach and strategic partnerships with original 
equipment manufacturers and distributors support its long-term potential.

For investors with a higher risk appetite, Varex’s current pricing and potential
upside present an opportunity to gain exposure to a company with essential products
in the growing medical devices market. However, it’s crucial to monitor developments
in the company’s financial performance and market conditions that could impact its
recovery trajectory.

As always, investors should conduct thorough due diligence, considering both the
risks and opportunities before making informed investment decisions in Varex Imaging
Corporation.

Share on: